CGB is a unicorn in the making, page-2

First 2 Last

Share
Profile

Follow
mwhite1

1,798 Posts.

84

08/09/19

00:11

Post #: 40351977
Share

Originally posted by z man: ↑

Folks, I am going to stick my neck out here and say that CGB is a unicorn in the making. It will be grass fed and grow nice and plump. This is IMHO only and here are some reasons why:

1. Great management team - yes great management team. Some people will think I am smoking grass, but look pass the bauxite projects and see what has been achieved in the short space of 2 years. The management team have managed to create a vertically integrated business and positioned itself as the leading Australian company in this sector. They have also secured partnerships with key international organisations and the Israel connection is much more valuable than Sholom has been given credit for.

2. T12 supply agreements - This is proof that the company is no longer promising a pie in the sky. There are actual wholesale supply agreements for their products. The Costco agreement is significant because it validates the quality of the product and the supply chain. Purchasers like Costco will only deal with organisations that can supply high quality products with ongoing supply. IMHO, the Vietnamese contract is just the beginning of many more to come. A hemp milk supply contract with a major retailer will send this off and trotting.

3. Medical cannabis - this is the true dark horse and the skies the limit. They just have to pull of one thing in this area and I will let you extrapolate the rest. Whether its MS human trial, cantab or a supply contract for medical grade cannabis raw material and something out of left field from the Israeli connection, you want to be riding this horse before it becomes a unicorn.

All IMHO, Zess will be a very wealthy Italian and some others as well. Good luck all, worth methinks.

Expand

Anyone else see the Facebook post another deal in Vietnam.

CGB Price at posting: 4.1¢ Sentiment: Buy Disclosure: Held
9 Upvote

1 Great analysis

Reply

Top Stories

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

HotCopper Highlights: Your most watched stocks for Week 46, 2024

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

First 2 Last

Add CGB (ASX) to my watchlist

CGB is a unicorn in the making, page-2

Top Stories

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Cyclone signs MOU with Vale for development of Iron Bear play

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Banshee's historic trenches prove rich in antimony and gold for GDM

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

HotCopper Highlights: Your most watched stocks for Week 46, 2024

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

Featured News